Literature DB >> 21590312

AS-48 bacteriocin: close to perfection.

Marina Sánchez-Hidalgo1, Manuel Montalbán-López, Rubén Cebrián, Eva Valdivia, Manuel Martínez-Bueno, Mercedes Maqueda.   

Abstract

Bacteriocin AS-48 is an intriguing molecule because of its unique structural characteristics, genetic regulation, broad activity spectrum, and potential biotechnological applications. It was the first reported circular bacteriocin and has been undoubtedly the best characterized for the last 25 years. Thus, AS-48 is the prototype of circular bacteriocins (class IV), for which the structure and genetic regulation have been elucidated. This review discusses the state-of-the-art in genetic engineering with regard to this circular protein, with the use of site-directed mutagenesis and circular permutation. Mutagenesis studies have been used to unravel the role of (a) different residues in the biological activity, underlining the relevance of several residues involved in membrane interaction and the low correlation between stability and activity and (b) three amino acids involved in maturation, providing information on the specificity of the leader peptidase and the circularization process itself. To investigate the role of circularity in the stability and biological properties of the enterocin AS-48, two different ways of linearization have been attempted: in vitro by limited proteolysis experiments and in vivo by circular permutation in the structural gene as-48A. The results summarized here show the significance of circularization on the secondary structure, potency and, especially, the stability of AS-48 and point as well to a putative role of the leader peptide as a protecting moiety in the pre-proprotein. Taken all together, the data available on circular bacteriocins support the idea that AS-48 has been engineered by nature to make a remarkably active and stable protein with a broad spectrum of activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21590312     DOI: 10.1007/s00018-011-0724-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  52 in total

1.  Production of cyclic peptides and proteins in vivo.

Authors:  C P Scott; E Abel-Santos; M Wall; D C Wahnon; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 2.  How proteins adapt to a membrane-water interface.

Authors:  J A Killian; G von Heijne
Journal:  Trends Biochem Sci       Date:  2000-09       Impact factor: 13.807

Review 3.  Enterocins in food preservation.

Authors:  Haider Khan; Steve Flint; Pak-Lam Yu
Journal:  Int J Food Microbiol       Date:  2010-03-11       Impact factor: 5.277

4.  An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.

Authors:  Hester E Hasper; Naomi E Kramer; James L Smith; J D Hillman; Cherian Zachariah; Oscar P Kuipers; Ben de Kruijff; Eefjan Breukink
Journal:  Science       Date:  2006-09-15       Impact factor: 47.728

5.  Mutational analysis of mesentericin y105, an anti-Listeria bacteriocin, for determination of impact on bactericidal activity, in vitro secondary structure, and membrane interaction.

Authors:  Dany Morisset; Jean-Marc Berjeaud; Didier Marion; Christian Lacombe; Jacques Frère
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

6.  Discovery and characterization of a linear cyclotide from Viola odorata: implications for the processing of circular proteins.

Authors:  David C Ireland; Michelle L Colgrave; Philip Nguyencong; Norelle L Daly; David J Craik
Journal:  J Mol Biol       Date:  2006-02-02       Impact factor: 5.469

Review 7.  Genetic features of circular bacteriocins produced by Gram-positive bacteria.

Authors:  Mercedes Maqueda; Marina Sánchez-Hidalgo; Matilde Fernández; Manuel Montalbán-López; Eva Valdivia; Manuel Martínez-Bueno
Journal:  FEMS Microbiol Rev       Date:  2007-11-20       Impact factor: 16.408

8.  Insights into the biosynthesis and stability of the lasso peptide capistruin.

Authors:  Thomas A Knappe; Uwe Linne; Lars Robbel; Mohamed A Marahiel
Journal:  Chem Biol       Date:  2009-12-24

9.  Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of alpha-thio-alpha-amino acid derivatives.

Authors:  Karen E Kawulka; Tara Sprules; Christopher M Diaper; Randy M Whittal; Ryan T McKay; Pascal Mercier; Peter Zuber; John C Vederas
Journal:  Biochemistry       Date:  2004-03-30       Impact factor: 3.162

Review 10.  Follow the leader: the use of leader peptides to guide natural product biosynthesis.

Authors:  Trent J Oman; Wilfred A van der Donk
Journal:  Nat Chem Biol       Date:  2010-01       Impact factor: 15.040

View more
  31 in total

Review 1.  Discovering the bacterial circular proteins: bacteriocins, cyanobactins, and pilins.

Authors:  Manuel Montalbán-López; Marina Sánchez-Hidalgo; Rubén Cebrián; Mercedes Maqueda
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

Review 2.  Thematic minireview series on circular proteins.

Authors:  David J Craik; Norma M Allewell
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

Review 3.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

4.  Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.

Authors:  Francisco R Fields; Giorgia Manzo; Charlotte K Hind; Jeshina Janardhanan; Ilona P Foik; Phoebe Do Carmo Silva; Rashna D Balsara; Melanie Clifford; Henry M Vu; Jessica N Ross; Veronica R Kalwajtys; Alejandro J Gonzalez; Tam T Bui; Victoria A Ploplis; Francis J Castellino; Albert Siryaporn; Mayland Chang; J Mark Sutton; A James Mason; Shaun Lee
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-21

5.  Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosis.

Authors:  Clara Aguilar-Pérez; Begoña Gracia; Liliana Rodrigues; Asunción Vitoria; Rubén Cebrián; Nathalie Deboosère; Ok-Ryul Song; Priscille Brodin; Mercedes Maqueda; José A Aínsa
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

6.  Enterocin AS-48 as Evidence for the Use of Bacteriocins as New Leishmanicidal Agents.

Authors:  María Ángeles Abengózar; Rubén Cebrián; José María Saugar; Teresa Gárate; Eva Valdivia; Manuel Martínez-Bueno; Mercedes Maqueda; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 7.  Lactic Acid Bacteria (LAB) and Their Bacteriocins as Alternative Biotechnological Tools to Control Listeria monocytogenes Biofilms in Food Processing Facilities.

Authors:  Anderson C Camargo; Svetoslav D Todorov; N E Chihib; D Drider; Luís A Nero
Journal:  Mol Biotechnol       Date:  2018-09       Impact factor: 2.695

Review 8.  The microbiome-shaping roles of bacteriocins.

Authors:  Simon Heilbronner; Bernhard Krismer; Heike Brötz-Oesterhelt; Andreas Peschel
Journal:  Nat Rev Microbiol       Date:  2021-06-01       Impact factor: 60.633

9.  Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.

Authors:  Francisco R Fields; Katelyn E Carothers; Rashna D Balsara; Victoria A Ploplis; Francis J Castellino; Shaun W Lee
Journal:  J Antibiot (Tokyo)       Date:  2018-02-20       Impact factor: 2.649

Review 10.  Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature.

Authors:  Paul G Arnison; Mervyn J Bibb; Gabriele Bierbaum; Albert A Bowers; Tim S Bugni; Grzegorz Bulaj; Julio A Camarero; Dominic J Campopiano; Gregory L Challis; Jon Clardy; Paul D Cotter; David J Craik; Michael Dawson; Elke Dittmann; Stefano Donadio; Pieter C Dorrestein; Karl-Dieter Entian; Michael A Fischbach; John S Garavelli; Ulf Göransson; Christian W Gruber; Daniel H Haft; Thomas K Hemscheidt; Christian Hertweck; Colin Hill; Alexander R Horswill; Marcel Jaspars; Wendy L Kelly; Judith P Klinman; Oscar P Kuipers; A James Link; Wen Liu; Mohamed A Marahiel; Douglas A Mitchell; Gert N Moll; Bradley S Moore; Rolf Müller; Satish K Nair; Ingolf F Nes; Gillian E Norris; Baldomero M Olivera; Hiroyasu Onaka; Mark L Patchett; Joern Piel; Martin J T Reaney; Sylvie Rebuffat; R Paul Ross; Hans-Georg Sahl; Eric W Schmidt; Michael E Selsted; Konstantin Severinov; Ben Shen; Kaarina Sivonen; Leif Smith; Torsten Stein; Roderich D Süssmuth; John R Tagg; Gong-Li Tang; Andrew W Truman; John C Vederas; Christopher T Walsh; Jonathan D Walton; Silke C Wenzel; Joanne M Willey; Wilfred A van der Donk
Journal:  Nat Prod Rep       Date:  2013-01       Impact factor: 13.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.